TANGO THERAPEUTICS
Tango Therapeutics operator of a biotechnology company created to discover novel drug targets and deliver the next generation of targeted therapies to people with cancer. The company's research leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.
TANGO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tangotx.com
Total Employee:
101+
Status:
Active
Contact:
(857) 320-4900
Total Funding:
351 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Amazon IPv6 Cloudflare Hosting Amazon Virginia Region Cloudflare COVID-19 Ruby On Rails Token Amazon Ohio Region
Similar Organizations
Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Catalym
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
iOnctura
iOnctura operates as a clinical-stage biotechnology company that specializes in developing a treatment for cancer.
Lumicell
Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions.
Senti Biosciences
Senti Biosciences is a developer of a programmable biology platform for cancer therapies.
Thyme Care
Thyme Care is a Nashville TN-based provider of oncology care management solutions.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Tango Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Tango Therapeutics
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Tango Therapeutics
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Tango Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Tango Therapeutics
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Tango Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Tango Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Post-IPO Equity - Tango Therapeutics
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - Tango Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Tango Therapeutics
Key Employee Changes
Official Site Inspections
http://www.tangotx.com Semrush global rank: 8.35 M Semrush visits lastest month: 560
- Host name: 230.47.230.35.bc.googleusercontent.com
- IP address: 35.230.47.230
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Tango Therapeutics"
Tango Therapeutics - Crunchbase Company Profile
Tango Therapeutics operator of a biotechnology company created to discover novel drug targets and deliver the next generation of targeted therapies to …See details»
Tango Therapeutics (TNGX) Company Profile & Description
3 days ago Company profile for Tango Therapeutics, Inc. (TNGX) stock, with a description, list of executives, contact details and other key facts.See details»
Tango Therapeutics
We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an approach that starts and ends with patients, we’re expanding the reach of genetically targeted therapies.See details»
Investor Relations | Tango Therapeutics, Inc
The Investor Relations website contains information about Tango Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Tango Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Explore Tango Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 113 news, and 9 literature, Disease Domain ...See details»
Investor Relations - Tango Therapeutics, Inc
Mar 12, 2025 The Investor Relations website contains information about Tango Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Leadership - tangotx.com
Leadership We are leaders in drug discovery, cancer biology, functional genomics and translational medicine pursuing the bold goal of tackling the genetic complexity of cancer. We are …See details»
Tango Therapeutics Announces Updates to Its Board of Directors
Aug 29, 2023 During this time, he was a member of the Novartis Oncology Executive Committee and European Pharma organization Board Level International Committee, and held roles …See details»
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 …
Dec 31, 2024 Tango Therapeutics shares its 2024 financial results and updates on its progress in developing innovative cancer treatments using synthetic lethality.See details»
Join Us - tangotx.com
Tango is a team of passionate problem solvers. Our discovery efforts begin and end with patients. We are driven by urgency and compassion, empowered by collaboration, courage and a …See details»
Pipeline - tangotx.com
A powerful approach We are leveraging the genetic principle of synthetic lethality and the power of our state-of-the-art CRISPR-based target discovery engine to discover and validate multiple novel targets each year. Our growing pipeline …See details»
News Releases | Tango Therapeutics, Inc
Jan 30, 2025 The Investor Relations website contains information about Tango Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.See details»
Approach - tangotx.com
A critical need Great strides have been made in understanding the genetic drivers of cancer, but too many patients still lack effective treatment. Existing therapies target many of the activated …See details»
Tango Therapeutics Reports Third Quarter 2024 Financial Results …
Sep 30, 2024 BOSTON -- (BUSINESS WIRE)--Nov. 6, 2024-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and …See details»
Corporate Governance | Tango Therapeutics, Inc
Corporate Governance Overview The Board of Directors of Tango Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this …See details»
Tango Therapeutics Announces the Addition of Shakti Narayan, …
The company’s programs are focused in the area of synthetic lethality, the interaction between two genes that causes cell death when both are inactivated. Tango was launched in 2017 with …See details»
Cancer NewCo - tangotx.com
This Presentation and any information communicated at any meetings related to your evaluation of the Business Combination are strictly confidential and should not be discussed outside your …See details»
Tango Therapeutics Reports First Quarter 2025 Financial Results …
Mar 31, 2025 For more information, please visit www.tangotx.com. Forward-Looking Statements Certain statements in this press release may be considered forward-looking statements.See details»
Tango Therapeutics to Participate in the 46th Annual Goldman …
BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango …See details»
Clinical Trials - tangotx.com
All Compassionate Use requests should come from a treating physician ([email protected]) and are evaluated on a case-by-case basis. We answer all …See details»